The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
出版年份 2014 全文链接
标题
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
作者
关键词
HSP90 inhibition, Ganetespib, Colorectal cancer, Combination therapy
出版物
INVESTIGATIONAL NEW DRUGS
Volume 32, Issue 4, Pages 577-586
出版商
Springer Nature
发表日期
2014-03-31
DOI
10.1007/s10637-014-0095-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib
- (2014) J. Acquaviva et al. MOLECULAR CANCER THERAPEUTICS
- Erratum to: Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
- (2013) Ganji Purnachandra Nagaraju et al. ANGIOGENESIS
- A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies
- (2013) Jonathan W Goldman et al. BMC CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
- (2013) Nishant Gandhi et al. CANCER BIOLOGY & THERAPY
- A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non-Small Cell Lung Cancer
- (2013) M. A. Socinski et al. CLINICAL CANCER RESEARCH
- Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer
- (2013) D. A. Proia et al. CLINICAL CANCER RESEARCH
- Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes
- (2013) Julie C. Friedland et al. INVESTIGATIONAL NEW DRUGS
- Clinicopathological relevance of BRAF mutations in human cancer
- (2013) Sahar Pakneshan et al. PATHOLOGY
- BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients’ Outcome
- (2013) Zacharenia Saridaki et al. PLoS One
- A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors
- (2013) Dan Zhou et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
- (2013) Jim Sang et al. Cancer Discovery
- Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF
- (2013) Alexandra Thiel et al. Frontiers in Oncology
- Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer
- (2012) T. Shimamura et al. CLINICAL CANCER RESEARCH
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
- (2012) David A. Proia et al. INVESTIGATIONAL NEW DRUGS
- Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer
- (2012) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting KRAS-Mutant Non-Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
- (2012) J. Acquaviva et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
- (2011) Kyung-Hun Lee et al. CANCER SCIENCE
- Evolvement of the treatment paradigm for metastatic colon cancer. From chemotherapy to targeted therapy
- (2011) Santiago Aparo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Factors Dictating Outcomes in Patients With Colorectal Cancer and Peritoneal Carcinomatosis: Selection, Resection, or Convection?
- (2011) Andrea Cercek et al. JOURNAL OF CLINICAL ONCOLOGY
- Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
- (2011) W. Ying et al. MOLECULAR CANCER THERAPEUTICS
- Personalized Colon Cancer Care in 2010
- (2011) Daniel V.T. Catenacci et al. SEMINARS IN ONCOLOGY
- Colorectal Cancer Screening: Update for 2011
- (2011) Linda C. Cummings et al. SEMINARS IN ONCOLOGY
- HSP90 at the hub of protein homeostasis: emerging mechanistic insights
- (2010) Mikko Taipale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
- (2009) Yanyan Li et al. DRUG RESISTANCE UPDATES
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- Targeting Hsp90: small-molecule inhibitors and their clinical development
- (2008) Tony Taldone et al. CURRENT OPINION IN PHARMACOLOGY
- HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
- (2008) T. T. Koll et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now